GRACEcast

What is the Value of Testing for Molecular Markers in Advanced NSCLC?


Listen Later

Memorial Sloan-Kettering Cancer Center medical oncologist Dr. Greg Riely explains how testing for specific mutations in patients with advanced NSCLC can guide prognosis and treatment recommendations.

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD